Kanya Rajangam - 05 Jul 2022 Form 3 Insider Report for Senti Biosciences, Inc. (SNTI)

Role: Chief Medical & Devt. Officer
Signature: /s/ Mike Rhee, attorney-in-fact
Issuer symbol: SNTI
Transactions as of: 05 Jul 2022
Transactions value $: $0
Form type: 3
Filing time: 15 Jul 2022, 17:45:11
Previous filing: 19 Jan 2022
Next filing: 20 Jul 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney